GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in medical investigation, largely due to its remarkable impact on controlling conditions such as second type diabetes and weight gain. New research have demonstrated that beyond glucose management, GLP-1 agonists offer benefits for heart health and p